XS15

TLR1/2 ligand

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XS15, covering 2024-05-09 to 2024-05-09. Get the full timeline:

Most recent: Clinical Trial Update: Personalized Multi-peptide Vaccination in Combination With the TLR1/2 Ligand XS15 in Cancer Patients